Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06815913

To Develop and Introduce Into Polyclinic Practice a Register of Patients with Experience of Myocardial Infarction and Acute Cerebrovascular Disease

This is a retrospective observational study using the methodology of creating medical registries. The expected number of patients included in the registry is about 2000 patients with myocardial infarction and/or ACVD of any duration and concomitant non-cardiac diseases of therapeutic profile in pilot healthcare organizations for any reason during 2019-2022 based on the source medical records data.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Republican Scientific and Practical Center of Cardiology

Minsk, 220036, Belarus

About this study

The implementation of the task results will improve the efficiency of secondary and tertiary prevention of diseases of the circulatory system - pathology that makes the greatest contribution to the main medical-demographic and socio-economic losses of the state by determining the number of groups with the highest risk of death in outpatient and polyclinic institutions among patients after myocardial infarction, ACVD, living in the Republic of Belarus, to create programs of additional measures to reduce morbidity and mortality of the population based on a comparison of register data and official statistical forms, which will ultimately affect the reduction in the incidence of non-fatal recurrent cardiovascular events in individuals after AMI, ACVD and / or their combination of any duration in the range of 0.2-1% of the indicators determined during the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients who applied to the pilot ambulatory health care organizations between 2019-2022 in order to identify and "look for" patients after acute cardiovascular event, but who were not monitored for that event for various reasons (statute of limitations, refusal, relocation, etc.);
  • All patients discharged from hospitals with a final diagnosis of AMI/ACVD, assigned territorially to the pilot polyclinics in the period 2019-2022.
  • Presence of a history of AMI and/or ACVD;
  • Age 18 years and older.

Exclusion criteria

  • No

Treatment and study plan

Primary outcomes

  1. Mortality from other causes

    Time frame: 3 years

    number of deaths from other diseases

Other outcomes

  1. Time to combined end point

    Time frame: 3 years

    non-fatal myocardial infarction or non-fatal cerebral stroke or coronary/carotid revascularization

  2. Proportion of patients with non-fatal myocardial infarction

    Time frame: 3 years

    non-fatal myocardial infarction

  3. Proportion of patients with non-fatal cerebral stroke

    Time frame: 3 years

    non-fatal cerebral stroke

  4. Proportion of patients with COVID-19 cases during follow-up

    Time frame: 3 years

    COVID-19 cases during follow-up

  5. Hospitalization due to cardiovascular diseases

    Time frame: 3 years

    Proportion of patients with hospitalization due to cardiovascular diseases

  6. COVID-19-related hospitalization

    Time frame: 3 years

    Pproportion of patients with COVID-19-related hospitalization

Sponsors and collaborators

Lead sponsor

State Institution "Republican Scientific and Practical Center" Cardiology, Belarus

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Feb 10, 2025
Registry last updated
Feb 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.